Allergic rhinitis (AR) or hayfever, is common, affecting one in five Australians.1 AR is a genuine health condition and should not be trivialised. It can significantly impact quality of life,2 therefore appropriate management is paramount. Self-medication is common,2 and 85% of people fail to select optimal treatment.3 Guidelines recommend intranasal corticosteroid sprays (INCS), such as
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.